Trial Profile
The Effect of Combination Therapy with Sofosbuvir and Ledipasvir in Patients with Chronic Type C Liver Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 18 Apr 2017 New trial record